This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pamela's Most Recent Article

Pfizer Ponies Up to Develop Long-acting Growth Hormone

12/16/14 - 11:38 AM EST

Opko gains $295 million up front for global license to develop, market long-acting HGH.

read more >

Other Articles by Pamela

Free Reports

Third Point's Daniel Loeb Tells Amgen it's Time to Break up

10/22/14 - 11:36 AM EDT

Amgen plans to expound on plans for the company at its Oct. 28 investor meeting.

read more >
Changing hospital dynamic leads Becton Dickinson to buy CareFusion

10/06/14 - 02:28 PM EDT

Cash, stock $12.2 billion deal would solidify BD position in infection control, respiratory care.

read more >
Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B

09/29/14 - 11:13 AM EDT

Perrigo gains women's health assets, Amag Pharmaceuticals buys Makena line in the transaction.

read more >
Auxilium Adopts Poison Pill in Response to $2.2B Endo Bid

09/17/14 - 11:50 AM EDT

The unsolicited bid comes a week after the Pennsylvania target announced a plant to cut 30% of its workforce.

read more >
Cognizant Expands Healthcare Information Technology With $2.7B Trizetto Buy

09/15/14 - 11:08 AM EDT

Teaneck, N.J.-based information technology solutions company Cognizant Technology Solutions is adding the operations of TriZetto to create a fully integrated healthcare technology and operations leader.

read more >
Roche, InterMune a Strategic Play in Midst of Inversions

08/27/14 - 09:19 AM EDT

As more companies seek tax savings through inversions, strategic reasons still remain for drug company deals.

read more >
Pfizer Bolsters Injectables by Buying InnoPharma

07/17/14 - 10:17 AM EDT

Fresh from AstraZeneca plc's rebuff of its $117 billion offer, Pfizer is setting its sights on a much smaller deal in the U.S. by acquiring InnoPharma.

read more >
St. Jude Medical Pays $200M for NeuroTherm

07/15/14 - 09:44 AM EDT

Target produces radiofrequency ablation systems, boosting the buyer's pain management business.

read more >
Salix to Invert, Merging With Cosmo Pharma

07/09/14 - 01:05 PM EDT

Building on the M&A trend for tax inversion deals, Salix Pharmaceuticals and Italy's Cosmo Pharmaceuticals plan to merge.

read more >
Page 1 of 2
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs